China Universal Asset Management Company’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.24M	Buy	4,271 +570	+15%	+$272K	0.17%	102
2025 Q4	$2.16M	Sell	3,701 -206	-5%	-$105K	0.17%	102
2025 Q3	$1.79M	Sell	3,907 -552	-12%	-$206K	0.15%	123
2025 Q2	$1.35M	Buy	4,459 +30	+0.7%	+$8.94K	0.13%	139
2025 Q1	$1.47M	Sell	4,429 -196	-4%	-$64.4K	0.14%	139
2024 Q4	$1.43M	Buy	4,625 +449	+11%	+$126K	0.13%	122
2024 Q3	$886K	Buy	4,176 +1,672	+67%	+$428K	0.1%	149
2024 Q2	$702K	Sell	2,504 -1,297	-34%	-$309K	0.1%	127
2024 Q1	$1.02M	Buy	3,801 +1,509	+66%	+$356K	0.13%	129
2023 Q4	$530K	Buy	2,292 +1,824	+390%	+$319K	0.1%	143
2023 Q3	$68.3K	Buy	468 +228	+95%	+$42.9K	0.02%	219
2023 Q2	$55.4K	Sell	240 -6	-2%	-$1.63K	0.02%	185
2023 Q1	$59.6K	Buy	246 +72	+41%	+$19.6K	0.02%	147
2022 Q4	$50.5K	Sell	174 -2,424	-93%	-$237K	0.02%	138
2022 Q3	$169K	Buy	+2,598	New	+$181K	0.07%	97